Aardvark Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jul '25 Jul 25, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	321	-	-	-
Enterprise Value	151	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.02
Quick Ratio	25.31	14.95	7.23	27.07
Current Ratio	25.86	15.05	7.50	27.72
Return on Equity (ROE)	-34.70%	-50.70%	-57.47%	-
Return on Assets (ROA)	-	-32.35%	-33.96%	-
Return on Capital (ROIC)	-24.18%	-34.67%	-36.34%	-
Buyback Yield / Dilution	-59.04%	-0.90%	-1.78%	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q